You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Flu vaccine response and HIV

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in United States (HIV-MAG vaccine, IL-12 pDNA adjuvant, VSV HIV gag vaccine)

Completed
  • HIV Infections
  • HIV-MAG vaccine
  • +4 more
  • New York, New York
  • +4 more
Oct 13, 2021

Qualitative, Qualitative, and Functional Studies Over First Year

Completed
  • Astrocytoma
  • +2 more
  • Hepatitis A Vaccine
  • +3 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Oct 28, 2021

HIV Trial in Switzerland, United States (DNA-HIV-PT123 vaccine, NYVAC-HIV-PT1 vaccine, NYVAC-HIV-PT4 vaccine)

Completed
  • HIV Infections
  • DNA-HIV-PT123 vaccine
  • +5 more
  • Birmingham, Alabama
  • +7 more
Oct 13, 2021

HIV Trial in United States (AIDSVAX B/E Vaccine, DNA-HIV-PT123 Vaccine, Placebo for DNA-HIV-PT123)

Completed
  • HIV Infections
  • AIDSVAX B/E Vaccine
  • +3 more
  • San Francisco, California
  • +6 more
Oct 13, 2021

Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT Lot 1 vaccine (GSK3888550A), RSV MAT Lot 2 vaccine

Completed
  • Respiratory Syncytial Virus Infections
  • RSV MAT Lot 1 vaccine (GSK3888550A)
  • +4 more
  • West Palm Beach, Florida
  • +35 more
Jul 14, 2022

HIV Trial in United States (GEO-D03 DNA vaccine, MVA/HIV62B (MVA62B) vaccine, Placebo for GEO-D03 DNA)

Completed
  • HIV Infections
  • GEO-D03 DNA vaccine
  • +3 more
  • Birmingham, Alabama
  • +3 more
Oct 13, 2021

HIV Trial in Botswana, United States (EP HIV-1090)

Completed
  • HIV Infections
  • EP HIV-1090
  • Boston, Massachusetts
  • +4 more
Oct 13, 2021

HIV, HIV Seronegativity Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452))

Completed
  • HIV Infections
  • HIV Seronegativity
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • Birmingham, Alabama
  • +12 more
Oct 13, 2021

Pneumococcal Infections, HIV Trial (PPV-23 Vaccine, PCV-13 Vaccine, Placebo Vaccine)

Withdrawn
  • Pneumococcal Infections
  • HIV Infections
  • PPV-23 Vaccine
  • +2 more
  • (no location specified)
Oct 28, 2021

HIV Trial in United States (VRC-HIVADV014-00-VP)

Completed
  • HIV Infections
  • VRC-HIVADV014-00-VP
  • Baltimore, Maryland
  • +7 more
Oct 13, 2021

COVID-19 Vaccination in Patients With HIV Infection

Recruiting
  • HIV Infections
  • Covid19
  • Biological/Vaccine: SARS-COV-2 VACCINE
  • Chongqing, China
    China
Sep 13, 2021

HIV Trial in United States (VRC rAd5 vaccine (rAd5 gag-pol/env A/B/C), rAd5 env A, rAd5 env B)

Completed
  • HIV Infections
  • VRC rAd5 vaccine (rAd5 gag-pol/env A/B/C)
  • +5 more
  • San Francisco, California
  • +7 more
Oct 13, 2021

HIV Trial in Rochester, Philadelphia, Nashville (PENNVAX-B, IL-12 DNA plasmids)

Completed
  • HIV Infections
  • PENNVAX-B
  • IL-12 DNA plasmids
  • Rochester, New York
  • +2 more
Oct 13, 2021

HIV Trial in United States (VRC-HIVDNA009-00-VP)

Completed
  • HIV Infections
  • VRC-HIVDNA009-00-VP
  • Birmingham, Alabama
  • +13 more
Oct 13, 2021

HIV Trial (GEO-D03 DNA Vaccine, MVA/HIV62B Vaccine, Placebo for DNA GEO-D03)

Withdrawn
  • HIV Infections
  • GEO-D03 DNA Vaccine
  • +3 more
  • (no location specified)
Nov 4, 2021

Influenza, Influenza Immunisation Trial in Rochester (Influenza Virus Quadrivalent Inactivated Vaccine)

Completed
Has Results
  • Influenza
  • Influenza Immunisation
  • Influenza Virus Quadrivalent Inactivated Vaccine
  • Rochester, New York
  • +1 more
Apr 29, 2021

HIV Trial in Brazil, United States (rMVA-HIV (rMVA-HIV env/gag + rMVA-HIV tat/rev/nef-RT), rFPV-HIV (rFPV-HIV env/gag + rFPV-HIV

Completed
  • HIV Infections
  • rMVA-HIV (rMVA-HIV env/gag + rMVA-HIV tat/rev/nef-RT)
  • +3 more
  • Birmingham, Alabama
  • +5 more
Oct 13, 2021

HIV Trial in Switzerland, United States (DNA Nat-B env, DNA CON-S env, DNA Mosaic env)

Completed
  • HIV Infections
  • DNA Nat-B env
  • +7 more
  • Birmingham, Alabama
  • +6 more
Oct 13, 2021

HIV Trial in Boston, Johannesburg, Cape Town (Sub C gp140 Vaccine, MF59C.1 Adjuvant, Sodium chloride)

Completed
  • HIV Infections
  • Sub C gp140 Vaccine
  • +2 more
  • Boston, Massachusetts
  • +3 more
Oct 13, 2021

HIV Trial in United States (VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade-Env) with adjuvant VRC-ADJDNA004-IL2-VP)

Completed
  • HIV Infections
  • VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade-Env) with adjuvant VRC-ADJDNA004-IL2-VP
  • Baltimore, Maryland
  • +6 more
Oct 13, 2021

HIV Infection, Rotavirus Infection Trial in Worldwide (RotaTeq, Placebo)

Completed
Has Results
  • HIV Infection
  • Rotavirus Infection
  • RotaTeq
  • Placebo
  • Gaborone, Botswana
  • +5 more
Nov 3, 2021

HIV Trial in United States (Profectus HIV MAG pDNA vaccine, IL-12, Placebo)

Completed
  • HIV Infections
  • Profectus HIV MAG pDNA vaccine
  • +2 more
  • Los Angeles, California
  • +12 more
Oct 28, 2021

HIV Infection Trial in South Africa (ALVAC-HIV, Bivalent Subtype C gp120/MF59®, ALVAC-HIV (vCP2438) Placebo)

Completed
Has Results
  • HIV Infection
  • ALVAC-HIV
  • +3 more
  • Durban, KwaZulu-Natal, South Africa
  • +4 more
Nov 3, 2021

Human Influenza Trial in Miami (Standard dose influenza vaccination, High dose influenza vaccination)

Recruiting
  • Human Influenza
  • Standard dose influenza vaccination
  • High dose influenza vaccination
  • Miami, Florida
    University of Miami
Nov 10, 2021

HIV Trial (DNA-HIV-PT123, NYVAC-HIV-PT1, NYVAC-HIV-PT4)

Withdrawn
  • HIV Infections
  • DNA-HIV-PT123
  • +4 more
  • (no location specified)
Oct 13, 2021